CRNX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.60%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $6,681,826.65

Crinetics Pharmaceuticals Insider Trading History Chart

Crinetics Pharmaceuticals Share Price & Price History

^$47.42

▲ +0.44 (0.94%)

As of 12/4/2025 05:00 PM ET

Days: 30 | 90 | 365

Crinetics Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/3/2025	Dana Pizzuti	Insider	Sell	5,000	$42.66	$213,300.00	66,270
10/1/2025	Dana Pizzuti	Insider	Sell	5,000	$41.81	$209,050.00	66,270
9/26/2025	Matthew K. Fust	Director	Sell	16,000	$44.75	$716,000.00	22,836
9/26/2025	Richard Scott Struthers	CEO	Sell	4,000	$45.00	$180,000.00	106,000
8/22/2025	Dana Pizzuti	Insider	Sell	30,000	$30.43	$912,900.00	66,270
8/20/2025	Dana Pizzuti	Insider	Sell	6,492	$29.18	$189,436.56	66,270
6/12/2025	Stephen F. Betz	Insider	Sell	97,483	$32.23	$3,141,877.09	99,713
3/19/2025	Dana Pizzuti	Insider	Sell	2,515	$34.20	$86,013.00	72,233
3/19/2025	Jeff E. Knight	COO	Sell	7,162	$34.20	$244,940.40	87,491
3/19/2025	Richard Scott Struthers	CEO	Sell	17,338	$34.20	$592,959.60	329,147
2/3/2025	Dana Pizzuti	Insider	Sell	5,000	$39.07	$195,350.00	31,748
11/22/2024	Jeff E. Knight	COO	Sell	501	$56.52	$28,316.52	51,653
10/3/2024	Dana Pizzuti	Insider	Sell	14,375	$54.63	$785,306.25	28,507
9/26/2024	Marc Wilson	CFO	Sell	25,000	$51.11	$1,277,750.00	111,092
9/10/2024	Stephen F. Betz	Insider	Sell	1,035	$51.50	$53,302.50	68,576
8/26/2024	Stephen F. Betz	Insider	Sell	3,000	$53.19	$159,570.00	69,611
7/25/2024	Marc Wilson	CFO	Sell	19,056	$53.88	$1,026,737.28	111,092
7/25/2024	Stephen F. Betz	Insider	Sell	3,000	$53.43	$160,290.00	75,611
7/15/2024	Jeff E. Knight	COO	Sell	27,000	$55.00	$1,485,000.00	51,653
7/15/2024	Marc Wilson	CFO	Sell	25,000	$55.00	$1,375,000.00	111,092
7/10/2024	Stephen F. Betz	Insider	Sell	3,000	$48.55	$145,650.00	78,611
7/5/2024	James Hassard	Insider	Sell	15,000	$44.08	$661,200.00	29,259
7/3/2024	Dana Pizzuti	Insider	Sell	14,375	$44.87	$645,006.25	28,507
6/28/2024	Marc Wilson	CFO	Sell	32,129	$43.61	$1,401,145.69	111,092
6/26/2024	Jeff E. Knight	COO	Sell	956	$44.38	$42,427.28	52,580
6/24/2024	Dana Pizzuti	Insider	Sell	9,500	$45.73	$434,435.00	27,786
6/21/2024	James Hassard	Insider	Sell	15,000	$44.66	$669,900.00	29,259
6/10/2024	Stephen F. Betz	Insider	Sell	3,000	$43.86	$131,580.00	83,643
5/28/2024	Stephen F. Betz	Insider	Sell	3,000	$47.49	$142,470.00	86,643
5/10/2024	Stephen F. Betz	Insider	Sell	3,000	$49.43	$148,290.00	89,643
5/8/2024	Richard Scott Struthers	CEO	Sell	107,448	$49.40	$5,307,931.20	257,485
4/15/2024	Dana Pizzuti	Insider	Sell	14,375	$44.47	$639,256.25	27,786
4/4/2024	Richard Scott Struthers	CEO	Sell	40,951	$49.17	$2,013,560.67	237,835
3/28/2024	Stephanie Okey	Director	Sell	17,500	$46.38	$811,650.00	6,000
3/22/2024	Jeff E. Knight	COO	Sell	32,359	$44.31	$1,433,827.29	52,580
3/20/2024	Dana Pizzuti	Insider	Sell	15,089	$44.06	$664,821.34	27,786
3/20/2024	Matthew K. Fust	Director	Sell	60,000	$44.14	$2,648,400.00	18,536
3/19/2024	Marc Wilson	CFO	Sell	6,942	$42.91	$297,881.22	110,630
1/25/2024	Stephen F. Betz	Insider	Sell	3,000	$37.26	$111,780.00	73,298
1/10/2024	Stephen F. Betz	Insider	Sell	3,000	$37.65	$112,950.00	76,298
1/3/2024	Dana Pizzuti	Insider	Sell	14,375	$35.00	$503,125.00	5,911
1/2/2024	Marc Wilson	CFO	Sell	10,000	$35.47	$354,700.00	96,055
12/26/2023	Stephen F. Betz	Insider	Sell	3,000	$35.89	$107,670.00	79,298
12/21/2023	Dana Pizzuti	Insider	Sell	9,583	$34.57	$331,284.31	5,911
12/11/2023	Stephen F. Betz	Insider	Sell	3,000	$32.87	$98,610.00	82,298
11/27/2023	Stephen F. Betz	Insider	Sell	3,000	$31.84	$95,520.00	85,298
11/3/2023	Richard Scott Struthers	CEO	Sell	199,082	$30.56	$6,083,945.92	135,522
11/1/2023	Marc Wilson	CFO	Sell	10,000	$28.75	$287,500.00	95,601
10/17/2023	Alan Seth Krasner	Insider	Sell	7,000	$30.00	$210,000.00	43,210
7/13/2023	Richard Scott Struthers	CEO	Sell	14,157	$20.35	$288,094.95	630,805
7/11/2023	Richard Scott Struthers	CEO	Sell	24,384	$20.14	$491,093.76	656,421
6/20/2023	Marc Wilson	CFO	Sell	30,922	$19.97	$617,512.34	95,158
6/16/2023	Richard Scott Struthers	CEO	Sell	50,000	$20.81	$1,040,500.00	680,805
6/8/2023	Coelho Rogerio Vivaldi	Director	Buy	5,000	$22.06	$110,300.00	5,000
4/5/2023	Dana Pizzuti	Insider	Sell	8,212	$16.15	$132,623.80	4,500
1/25/2023	Stephen F. Betz	Insider	Sell	8,336	$21.07	$175,639.52	67,815
1/17/2023	Stephen F. Betz	Insider	Sell	3,126	$18.00	$56,268.00	76,151
12/15/2022	Stephen F. Betz	Insider	Sell	3,126	$16.00	$50,016.00	82,403

SEC Filings (Institutional Ownership Changes) for Crinetics Pharmaceuticals (NASDAQ:CRNX)

98.51% of Crinetics Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Crinetics Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/26/2025	JPMorgan Chase & Co.	1,258,722	$52.43M	0.0%	+279.2%	1.327%
11/21/2025	CIBC Bancorp USA Inc.	9,639	$0.40M	0.0%	N/A	0.010%
11/17/2025	CANADA LIFE ASSURANCE Co	22,561	$0.98M	0.0%	+17.4%	0.024%
11/17/2025	Dark Forest Capital Management LP	5,126	$0.21M	0.0%	N/A	0.005%
11/17/2025	Vestal Point Capital LP	750,000	$31.24M	1.4%	-50.0%	0.790%
11/17/2025	Paradigm Biocapital Advisors LP	2,550,774	$106.24M	3.0%	+8.8%	2.688%
11/17/2025	Parkman Healthcare Partners LLC	73,725	$3.07M	0.3%	+0.4%	0.078%
11/17/2025	Millennium Management LLC	216,244	$9.01M	0.0%	-39.5%	0.228%
11/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	42,009	$1.75M	0.0%	-22.2%	0.044%
11/17/2025	Jain Global LLC	5,929	$0.25M	0.0%	N/A	0.006%
11/17/2025	Farallon Capital Management LLC	5,770,098	$240.33M	1.0%	+24.2%	6.081%
11/17/2025	First Light Asset Management LLC	941,516	$39.21M	3.7%	+9.0%	0.992%
11/17/2025	Brevan Howard Capital Management LP	11,969	$0.50M	0.0%	N/A	0.013%
11/17/2025	Checkpoint Capital L.P.	260,000	$10.83M	3.6%	N/A	0.274%
11/17/2025	Bank of America Corp DE	601,042	$25.03M	0.0%	+4.8%	0.633%
11/17/2025	Ameriprise Financial Inc.	614,816	$25.61M	0.0%	+157.7%	0.648%
11/14/2025	Schonfeld Strategic Advisors LLC	81,847	$3.41M	0.0%	-44.7%	0.086%
11/14/2025	Creative Planning	40,572	$1.69M	0.0%	+42.5%	0.043%
11/14/2025	California State Teachers Retirement System	84,179	$3.51M	0.0%	+11.5%	0.089%
11/14/2025	ADAR1 Capital Management LLC	248,368	$10.35M	1.0%	+367.5%	0.262%
11/14/2025	Zurcher Kantonalbank Zurich Cantonalbank	18,639	$0.78M	0.0%	+15.9%	0.020%
11/14/2025	Brooklyn Investment Group	5,542	$0.23M	0.0%	+14,878.4%	0.006%
11/14/2025	UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC	217,690	$9.07M	0.0%	-35.0%	0.229%
11/14/2025	Two Sigma Investments LP	49,699	$2.07M	0.0%	-5.8%	0.052%
11/14/2025	Prosight Management LP	328,684	$13.69M	3.2%	+10.3%	0.346%
11/14/2025	Wellington Management Group LLP	8,381,991	$349.11M	0.1%	+44.3%	8.833%
11/14/2025	Glenmede Investment Management LP	14,522	$0.61M	0.0%	-15.2%	0.015%
11/13/2025	Invesco Ltd.	89,393	$3.72M	0.0%	+14.4%	0.094%
11/13/2025	Pier Capital LLC	75,000	$3.12M	0.5%	-47.4%	0.079%
11/13/2025	UBS Group AG	407,722	$16.98M	0.0%	+27.2%	0.430%
11/13/2025	BNP Paribas Financial Markets	23,967	$1M	0.0%	+52.1%	0.025%
11/13/2025	Mackenzie Financial Corp	5,939	$0.25M	0.0%	N/A	0.006%
11/13/2025	Franklin Resources Inc.	20,400	$0.85M	0.0%	-96.9%	0.021%
11/13/2025	Legal & General Group Plc	93,809	$3.91M	0.0%	-3.8%	0.099%
11/13/2025	Swiss National Bank	172,500	$7.19M	0.0%	+2.2%	0.182%
11/13/2025	WINTON GROUP Ltd	68,200	$2.84M	0.1%	N/A	0.072%
11/13/2025	Russell Investments Group Ltd.	148,982	$6.21M	0.0%	-4.7%	0.157%
11/13/2025	Schroder Investment Management Group	87,318	$3.80M	0.0%	-38.1%	0.092%
11/13/2025	Natixis Advisors LLC	51,746	$2.16M	0.0%	+9.8%	0.055%
11/12/2025	Barclays PLC	183,236	$7.63M	0.0%	-37.3%	0.193%
11/12/2025	GW&K Investment Management LLC	850,546	$35.43M	0.3%	-12.4%	0.896%
11/12/2025	Dimensional Fund Advisors LP	377,802	$15.74M	0.0%	+115.6%	0.398%
11/12/2025	Legato Capital Management LLC	5,685	$0.24M	0.0%	N/A	0.006%
11/12/2025	Victory Capital Management Inc.	233,386	$9.72M	0.0%	-10.8%	0.246%
11/12/2025	Segall Bryant & Hamill LLC	180,849	$7.53M	0.1%	+2.5%	0.191%
11/12/2025	Fisher Asset Management LLC	758,357	$31.59M	0.0%	+2.9%	0.799%
11/12/2025	Rafferty Asset Management LLC	6,179	$0.26M	0.0%	-93.2%	0.007%
11/12/2025	American Century Companies Inc.	1,133,535	$47.21M	0.0%	+33.6%	1.195%
11/12/2025	Handelsbanken Fonder AB	32,100	$1.34M	0.0%	+31.0%	0.034%
11/12/2025	DNB Asset Management AS	9,155	$0.38M	0.0%	-10.3%	0.010%
11/12/2025	Intech Investment Management LLC	22,225	$0.93M	0.0%	-47.9%	0.023%
11/10/2025	RWA Wealth Partners LLC	5,696	$0.24M	0.0%	N/A	0.006%
11/10/2025	TD Asset Management Inc	203,548	$8.48M	0.0%	+0.5%	0.216%
11/10/2025	Ameritas Investment Partners Inc.	7,555	$0.32M	0.0%	-17.6%	0.008%
11/10/2025	China Universal Asset Management Co. Ltd.	16,508	$0.69M	0.1%	-12.3%	0.018%
11/7/2025	Fiera Capital Corp	435,425	$18.14M	0.1%	-2.0%	0.462%
11/7/2025	NEOS Investment Management LLC	22,300	$0.93M	0.0%	-61.6%	0.024%
11/7/2025	Skandinaviska Enskilda Banken AB publ	178,584	$7.44M	0.0%	+885.7%	0.190%
11/7/2025	Vanguard Group Inc.	9,170,129	$381.94M	0.0%	-0.9%	9.737%
11/7/2025	JPMorgan Chase & Co.	1,258,722	$52.43M	0.0%	+279.2%	1.337%
11/7/2025	State of New Jersey Common Pension Fund D	72,349	$3.01M	0.0%	+15.7%	0.077%
11/7/2025	PNC Financial Services Group Inc.	5,952	$0.25M	0.0%	+5.8%	0.006%
11/7/2025	Aberdeen Group plc	339,949	$14.16M	0.0%	+21.3%	0.361%
11/7/2025	GF Fund Management CO. LTD.	2,026	$84K	0.0%	-14.7%	0.002%
11/6/2025	Abich Financial Wealth Management LLC	1,632	$68K	0.0%	N/A	0.002%
11/6/2025	Rhumbline Advisers	131,522	$5.48M	0.0%	-2.8%	0.140%
11/6/2025	Profund Advisors LLC	10,091	$0.42M	0.0%	-48.8%	0.011%
11/6/2025	ProShare Advisors LLC	18,804	$0.78M	0.0%	-14.7%	0.020%
11/6/2025	Oppenheimer & Co. Inc.	5,197	$0.22M	0.0%	N/A	0.006%
11/6/2025	Oppenheimer Asset Management Inc.	5,297	$0.22M	0.0%	N/A	0.006%
11/6/2025	Candriam S.C.A.	745,094	$31.03M	0.2%	+7.4%	0.791%
11/5/2025	Alps Advisors Inc.	47,415	$1.98M	0.0%	-6.2%	0.050%
11/5/2025	Bessemer Group Inc.	3,100	$0.13M	0.0%	+1,165.3%	0.003%
11/5/2025	Envestnet Asset Management Inc.	52,665	$2.19M	0.0%	-2.9%	0.056%
11/4/2025	Principal Financial Group Inc.	6,923	$0.29M	0.0%	N/A	0.007%
11/4/2025	Lisanti Capital Growth LLC	22,890	$0.95M	0.2%	N/A	0.024%
11/3/2025	AlphaQuest LLC	14,708	$0.61M	0.0%	-47.1%	0.016%
11/3/2025	Arizona State Retirement System	26,300	$1.10M	0.0%	+2.0%	0.028%
11/3/2025	New York State Common Retirement Fund	148,277	$6.18M	0.0%	+5.2%	0.157%
10/31/2025	Vanguard Personalized Indexing Management LLC	7,485	$0.31M	0.0%	N/A	0.008%
10/30/2025	Teacher Retirement System of Texas	21,767	$0.91M	0.0%	-8.5%	0.023%
10/30/2025	Strs Ohio	1,200	$50K	0.0%	-29.4%	0.001%
10/30/2025	Covestor Ltd	1,445	$60K	0.0%	+23,983.3%	0.002%
10/30/2025	Universal Beteiligungs und Servicegesellschaft mbH	387,925	$16.16M	0.0%	+13.5%	0.412%
10/23/2025	SG Americas Securities LLC	32,271	$1.34M	0.0%	+59.1%	0.034%
10/21/2025	Altfest L J & Co. Inc.	5,412	$0.23M	0.0%	-27.4%	0.006%
10/21/2025	Moody Aldrich Partners LLC	115,543	$4.81M	0.9%	-16.1%	0.123%
10/20/2025	Lewis Asset Management LLC	29,675	$1.24M	0.5%	+61.3%	0.032%
10/16/2025	Rice Hall James & Associates LLC	174,077	$7.25M	0.4%	N/A	0.185%
10/14/2025	Farther Finance Advisors LLC	842	$35K	0.0%	+523.7%	0.001%
10/9/2025	Voya Investment Management LLC	34,694	$1.45M	0.0%	-29.1%	0.037%
10/7/2025	Assenagon Asset Management S.A.	12,338	$0.51M	0.0%	N/A	0.013%
10/7/2025	Sanders Morris Harris LLC	21,100	$0.88M	0.1%	N/A	0.022%
10/1/2025	Praxis Investment Management Inc.	5,805	$0.24M	0.0%	N/A	0.006%
9/4/2025	Osaic Holdings Inc.	2,478	$75K	0.0%	+126.1%	0.003%
8/27/2025	Orion Porfolio Solutions LLC	16,866	$0.49M	0.0%	-4.6%	0.018%
8/27/2025	Squarepoint Ops LLC	42,070	$1.21M	0.0%	-69.8%	0.045%
8/16/2025	Headlands Technologies LLC	1,055	$30K	0.0%	N/A	0.001%
8/15/2025	Tower Research Capital LLC TRC	12,768	$0.37M	0.0%	+2,295.5%	0.014%
8/15/2025	Exome Asset Management LLC	62,700	$1.80M	1.0%	+22.2%	0.067%

Data available starting January 2016

Crinetics Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. The company's lead product candidate is paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist, which is in Phase 3 trial for the treatment of acromegaly; and Phase 2 trial for treating carcinoid syndrome associated with neuroendocrine tumors. It is also developing CRN04894, an investigational oral nonpeptide product candidate to antagonize the adrenocorticotrophic hormone (ACTH) receptor that has completed a Phase 1 study for the treatment of diseases caused by excess ACTH, including congenital adrenal hyperplasia and Cushing's disease. In addition, the company is developing antagonists of the parathyroid hormone (PTH) receptor for the treatment of primary hyperparathyroidism and humoral hypercalcemia of malignancy, and other diseases of excess PTH; identified investigational orally available somatostatin receptor type 3 targeted nonpeptide agonists for the treatment of autosomal dominant polycystic kidney disease; and developing thyroid-stimulating hormone receptor antagonists for the treatment of graves' disease and thyroid eye disease, as well as Oral GLP-1 and GIP nonpeptides for the treatment of diabetes and obesity. Crinetics Pharmaceuticals, Inc. was incorporated in 2008 and is headquartered in San Diego, California.

Today's Range

Now: $47.42

$46.63

$48.62

50 Day Range

MA: $43.23

$40.00

$47.42

52 Week Range

Now: $47.42

$24.10

$60.34

Volume

753,359 shs

Average Volume

1,486,857 shs

Market Capitalization

$4.50 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.2

Who are the company insiders with the largest holdings of Crinetics Pharmaceuticals?: Crinetics Pharmaceuticals' top insider investors include:
Richard Scott Struthers (CEO)
Marc Wilson (CFO)
Stephen F Betz (Insider)
Jeff E Knight (COO)
Dana Pizzuti (Insider)
James Hassard (Insider)
Matthew K Fust (Director)
Stephanie Okey (Director)
Learn More about top insider investors at Crinetics Pharmaceuticals.
Who are the major institutional investors of Crinetics Pharmaceuticals?: Crinetics Pharmaceuticals' top institutional investors include:
Vanguard Group Inc. — 9.74%
Wellington Management Group LLP — 8.83%
Farallon Capital Management LLC — 6.08%
Paradigm Biocapital Advisors LP — 2.69%
JPMorgan Chase & Co. — 1.34%
JPMorgan Chase & Co. — 1.33%
Learn More about top institutional investors of Crinetics Pharmaceuticals stock.
Which institutional investors are selling Crinetics Pharmaceuticals stock?: During the previous quarter, CRNX stock was sold by these institutional investors:
Vestal Point Capital LP
Franklin Resources Inc.
Millennium Management LLC
GW&K Investment Management LLC
UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC
Barclays PLC
Vanguard Group Inc.
Rafferty Asset Management LLC
During the last year, company insiders that have sold Crinetics Pharmaceuticals company stock include:
Richard Scott Struthers (CEO)
Marc Wilson (CFO)
Stephen F Betz (Insider)
Jeff E Knight (COO)
Dana Pizzuti (Insider)
Learn More investors selling Crinetics Pharmaceuticals stock.
Which institutional investors are buying Crinetics Pharmaceuticals stock?: In the last quarter, CRNX stock was bought by institutional investors including:
Wellington Management Group LLP
Farallon Capital Management LLC
JPMorgan Chase & Co.
JPMorgan Chase & Co.
Ameriprise Financial Inc.
American Century Companies Inc.
Checkpoint Capital L.P.
Paradigm Biocapital Advisors LP